Table 1.
Demographic Characteristics of the Study Population
| Variables | Control | CMV+/PSS | P * |
|---|---|---|---|
| Patients (n) | 20 | 19 | — |
| Eyes (n) | 20 | 19 | — |
| Gender, male:female (n) | 8:12 | 15:4 | <0.005† |
| Age (y), mean ± SD (range) | 73.5 ± 3.8 (58–87) | 62.7 ± 7.4 (39–86) | <0.005‡ |
| IOP (mm Hg), mean ± SD (range) | 13.5 ± 0.7 (12–16) | 19.6 ± 4.0 (8–34) | <0.001‡ |
| Corneal endothelial cells (n), mean ± SD (range) | 2644.9 ± 123.5 (2321–3251) | 2027.1 ± 355.5 (388–2778) | <0.001‡ |
| Glaucoma eye drops (n), mean ± SD (range) | — | 0.8 ± 2.1 (0–4) | — |
| Aqueous TNF-α level (pg/mL), mean ± SD (range) | 4.0 ± 9.1 (0-34.71) | 45.3 ± 28.8 (3.4-79.5) | <0.0001‡ |
*
All P represent a statistically significant difference between control and CMV+/PSS (Steel–Dwass test).
†
Fisher's exact test.
‡
Mann–Whitney U-test.